Six of these loci had previously been reported to be hypermethylated in prostate cancers, whereas ASC1 and SFRP1 had been reported as frequently hypermethylated in other cancers, but not been studied in prostate cancer before. This evidence concerns the gene SFRP1 and prostate carcinoma.